1. Home
  2. LAW vs NERV Comparison

LAW vs NERV Comparison

Compare LAW & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CS Disco Inc.

LAW

CS Disco Inc.

HOLD

Current Price

$3.65

Market Cap

274.2M

Sector

Technology

ML Signal

HOLD

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$4.67

Market Cap

301.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAW
NERV
Founded
2013
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
274.2M
301.6M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
LAW
NERV
Price
$3.65
$4.67
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$8.00
$10.50
AVG Volume (30 Days)
378.2K
133.0K
Earning Date
05-06-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
22.58
N/A
EPS
N/A
N/A
Revenue
$156,849,000.00
$41,175,600.00
Revenue This Year
$11.23
N/A
Revenue Next Year
$10.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
8.29
N/A
52 Week Low
$2.45
$1.57
52 Week High
$9.11
$12.46

Technical Indicators

Market Signals
Indicator
LAW
NERV
Relative Strength Index (RSI) 44.94 38.38
Support Level $3.34 $3.69
Resistance Level $4.60 $5.61
Average True Range (ATR) 0.24 0.41
MACD -0.02 0.01
Stochastic Oscillator 21.10 19.83

Price Performance

Historical Comparison
LAW
NERV

About LAW CS Disco Inc.

CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: